// App-Quantinova.ai

13720 2014 AHA : High Serum Levels of Thrombospondin-2 Correlate with Poor Prognosis of Patients with Heart Failure with Preserved Ejection Fraction

Researchers

Presenter

  • Yasuhiro Izumiya

Principal Investigators

  • Shinsuke Hanatani

  • Yoshiro Onoue

  • Satoshi Araki

  • Hisao Ogawa

Medical Centers

  • Kumamoto Univ., Kumamoto, Japan.

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Heart failure with preserved ejection fraction

  • Myocardial infarction

  • Arrhythmia

  • Congestive heart failure

  • Stroke

Biomarkers

  • B-type natriuretic peptide

  • Thrombospondin-2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved